Study of ANX005 in Adults With Amyotrophic Lateral Sclerosis (ALS)
NCT04569435
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
DRUG:
ANX005
Sponsor
Annexon, Inc.